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Abstract The aim of this study was to investigate the
inhibitory effect of various dairy powders and milk constit-
uents on the adhesion of a clinical isolate of Streptococcus
mutans to hydroxylapatite (HA), an analogue of tooth
enamel. Adhesion of a microorganism to a cell surface such
as epithelial cells or tooth enamel is considered to be the first
step in pathogenesis. Inhibiting this process may have ther-
apeutic effects in vivo. The adherence assays were
performed by incubating S. mutans with HA in the presence
of each test material for 45 min, followed by centrifugal
separation of the HA. Unbound bacteria were then quantified
using a fluorescent dye. Sweet and Acid WPC80, buttermilk
powder and cream powder were found to very effectively
inhibit adherence of S. mutans to phosphate-buffered saline
coated HA (PBS-HA). Sodium caseinate and the casein
fractions a-,b- and j-casein were also found to show high
levels of anti-adhesive activity. A selection of test materials
were assessed using saliva-coated HA (S-HA), and similar
trends were observed. The results suggest commercial dairy
powders, and certain milk proteins, can inhibit adhesion of
S. mutans to HA and may have potential to control dental
caries.
Keywords Dairy powders  Adhesion  S. mutans 
Fluorescence
Introduction
Streptococcus mutans is consistently present in dental
plaque biofilms and is considered to be the primary
organism involved in the formation of dental caries [1].
Dental caries is regarded as one of the most common
bacterial infections in humans [2]. Control of dental plaque
currently relies on good oral hygiene such as brushing and
flossing, the effects of which are increased when used in
conjunction with antimicrobials [3]. Bacterial adhesion is
regarded as the first step in pathogenesis, thus, a logical
approach to prophylaxis of dental caries centers upon the
inhibition of adhesion of S. mutans to the tooth surface [4].
Hydroxylapatite (HA) can be used as a suitable in vitro
model of adherence to tooth surfaces. The HA model [5] is
currently the most common in vitro system in use for the
study of adhesion of oral bacteria such as S. mutans [6, 7].
Phosphate-buffered saline coated HA (PBS-HA) was used
in the majority of our adherence assays, however, some of
our adhesion experiments were carried out in the presence
of saliva for comparison purposes. Employing PBS-HA
was the preferred approach for optimizing our adherence
assay since it eliminated problems of variability and
instability that are associated with use of saliva [8].
A vital aspect of the study of bacterial adhesion and
attachment to surfaces is the requirement of accurate
quantification of the microbial population attaching to a
particular surface [9]. A fluorescence-based 96 well plate
assay is one such approach that has been successfully
employed by researchers such as Gaines et al. [7]. Many
other researchers use radiolabelled bacteria for the quan-
tification of inhibition of adhesion of cariogenic bacteria to
HA. However, radiolabelling of bacteria or other reagents
requires special laboratory space and techniques, and can
be hazardous [9]. A major benefit of fluorescence-based
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methods is their speed in comparison to visual counting [9].
The fluorescence-based method used in this study is high-
throughput and reliable, and was specifically designed to
measure the percentage inhibition of adhesion of S. mutans
to HA without the use of radioactivity.
Total milk protein, casein and whey proteins have been
shown to possess anticariogenic properties, primarily due
to the fact that they have a positive effect on the demin-
eralization of enamel [10]. Recent research has shown that
commercial whey protein concentrate can prevent both
growth and adhesion of S. mutans, particularly following
enzyme treatment [11]. The objective of the present study
was firstly to determine the effect of a variety of com-
mercial dairy powders on the adhesion of S. mutans to HA,
and also to examine the effects of a selection of individual
milk protein constituents on this adhesion process.
Materials and methods
Source and preparation of dairy powders
Whey protein isolate (WPI), whey powder (WP), demi-
neralised whey (DW), sweet whey protein concentrate 80
(WPC, 80% protein), acid WPC 80 and sweet WPC 35
powders were supplied by Carbery Milk Products (Bal-
lineen, Cork, Ireland). Buttermilk powder (BMP), cream
powder (CP) and sodium caseinate were supplied by Kerry
Group plc (Tralee, Co. Kerry, Ireland). a-lactalbumin, b-
lactoglobulin (A and B), BSA, lactoferrin, a-casein, b-
casein, j-casein and albumin from chicken egg white
(grade V) were obtained from Sigma (Poole, Dorset, UK).
Analysis of dairy powders
Compositional analysis was performed for each dairy
powder using standard methods. Ash content was deter-
mined according to the international dairy federation (IDF)
standard method [12]. Fat content was determined accord-
ing to the method of Ro¨se-Gottlieb [13], protein content was
determined by the Kjeldahl method [14] and the moisture
content was determined by the IDF reference method [15].
Bacterial isolate and growth conditions
A clinical isolate of S. mutans (LAN-SVHERC-1997sm1)
was obtained from the Microbiology Department, St.
Vincent’s University Hospital, Dublin, Ireland. The iden-
tity of the bacterial isolate was confirmed by 16S RNA
analysis (Accugenix, Delaware, USA), and maintained on
ProtectTM Bacterial Preserve beads (Technical Service
Consultants Ltd., Lancashire, UK) at -80 C. For each
assay, a single bead from the frozen stock culture was used
to inoculate a columbia blood agar plate (CBA; Oxoid,
Hampshire, England) and grown aerobically at 37 C for
48 h. A single colony of S. mutans was used to inoculate
20 mL of brain heart infusion (BHI) broth (BHI Broth;
LabM, Lancashire, UK) and grown under aerobic condi-
tions at 37 C for 18 h. The culture was then subjected to
centrifugation at 3,220 9 g (Eppendorf 5810R, Cam-
bridge, UK) for 10 min and the pellet was resuspended in
sterile phosphate-buffered saline (PBS; Oxoid, Hampshire,
England). Following a second centrifugation step, the
bacterial pellet was resuspended in PBS, and the optical
density (OD) at 630 nm was measured using a Multiskan
Ascent spectrophotometer (Thermo Electron Corporation,
Finland), and subsequently adjusted to 0.2 by appropriate
dilution with sterile PBS. Viable colony counts were per-
formed to verify the number of colony forming units per
millilitre (CFU mL-1), typically 1 9 108 CFU mL-1.
Preparation of hydroxylapatite
Hydroxylapatite (HA) beads were supplied by Merck
(Darmstadt, Germany). Size profile analysis of this HA was
carried out using a Malvern Mastersizer (Malvern Instru-
ments Ltd., Worcestershire, UK), and the average diameter
(D [3, 4]) of the HA beads was found to be approximately
10 lm. PBS-HA was prepared immediately before use in
the adherence assays, and did not undergo any pre-treat-
ment steps. S-HA was prepared similar to the protocol set
out by Gibbons and Etherden [16]. Briefly, parafilm-stilu-
mated whole saliva was collected in an ice-chilled tube
from two healthy donors (1 male, 1 female) at least 1 h after
eating, drinking or brushing of teeth. The saliva was heated
at 60 C for 30 min to inactivate degenerative enzymes, and
subsequently centrifuged at 12,000 9 g for 15 min. The
pellet was discarded and the supernatant (i.e. clarified whole
saliva) was used to prepare a 7.5 mg mL-1 solution of
hydroxylapatite. Aliquots of saliva-coated hydroxylapatite
(S-HA) were dispensed into the wells of a 96-well V-bottom
plate (Sarstedt, Newton, North Carolina, USA), and incu-
bated at 30 C for 1 h with gentle agitation (4.5 9 g).
Following this, the microtitre plate was centrifuged at
805 9 g for 2 min, the supernatants discarded and the S-
HA pellets washed twice with sterile pre-warmed PBS to
remove excess saliva. The S-HA pellets were subsequently
resuspended in sterile PBS for use in the adherence assay.
Preparation of fluorescent dye
Syto 13 dye was supplied (Molecular Probes, Oregon,
USA) as a 5 mM solution in dimethylsulphoxide (DMSO).
Preliminary studies established 5 lM, prepared in sterile
PBS, to be a suitable concentration of fluorescent dye for
our study (data not shown). A standard curve of relative
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fluorescent units (RFU) vs. colony forming units per mil-
liliter (CFU mL-1) was constructed (Fig. 1), and the
relationship between RFU and CFU mL-1 could be rep-
resented as 1 RFU & 1 9 104 CFU mL-1.
Adherence assay
Adherence assays using PBS-HA and S-HA were carried
out in a similar manner. A preliminary study was con-
ducted to establish the time required for maximum binding
of bacteria to the HA (data not shown), and 45 min was the
time allocated for adherence to occur. All dairy powders
and milk and whey components were prepared to a stock
solution concentration of 6 mg mL-1 by dissolution of
dried powders in sterile PBS. A sterile polystyrene 96-well
half-area microtitre plate (Nunc, Roskilde, Denmark) was
set up as follows: 50 lL of dairy powder or milk compo-
nent suspension (prepared in sterile PBS) at various
concentrations was added to all wells. 50 lL of PBS-HA or
S-HA (7.5 mg mL-1) was added to the wells, followed by
50 lL of the bacterial suspension, so that the final volume
of all wells was 150 lL. Control wells (no bacteria and/or
HA) were included in each assay. The plate was incubated
for 45 min at room temperature, and manually inverted at
5 min intervals to prevent settling of the HA suspension.
The plate was subsequently centrifuged at 201 9 g (Ep-
pendorf 5810R, Cambridge, UK) to sediment the HA and
adhering bacteria, leaving the non-adhering bacteria in
suspension. These non-adhering bacteria were labeled with
10 lL of 5 lM Syto 13 fluorescent dye.
Quantification of inhibition of bacterial adhesion to HA
100 lL of supernatant (see ‘Adherence assay’) containing
the non-adhering bacteria was transferred from each well
of the half-area plate to the corresponding wells of a black
microtitre plate (Costar, Corning Inc., Corning, USA). This
plate was allowed to stand at room temperature for 5 min
in the dark before reading the fluorescence using a Fluo-
roskan Ascent plate reader (Thermo Electron Corporation,
Finland). The excitation wavelength was 485 nm and the
emission intensity was monitored at 538 nm. Three mea-
surements were taken at 5 min intervals, and the average
fluorescence calculated. The fluorescence due to the num-
ber of bacteria present in the supernatant was determined as
a direct readout from the fluorimeter as relative fluorescent
units (RFU). The background fluorescence due to non-
bacterial components of the assay (i.e. dairy powder or
milk component, PBS and HA) were subtracted. The per-
centage inhibition of adhesion was calculated as follows:
ðFluorescence due to unbound bacteria=Fluorescence
due to total input bacteriaÞ  100
Note: Because the adherence assay described here
measures the unbound population (i.e. the non-adhering
microorganisms), experiments were performed to verify
that the sum of the RFU values of all populations (i.e.
bound and unbound bacteria) was equal to the RFU value
of the control wells containing the total input bacteria (data
not shown).
Statistical analysis of data
All experiments were repeated at least three times. Results
were expressed as the mean ± standard deviation (SD).
Differences between treatments were determined using the
general linear models (GLM) function of SAS Version
9.1.3. Data were considered significantly different if
P \ 0.05.
Results and discussion
Composition of dairy powders
Table 1 shows the composition of dairy powders used in
the present study. These were typical of their product types.
Assessment of anti-adhesive effect of whey and dairy
products
In every assay there was a small proportion (*10–20%) of
bacteria that did not bind to PBS-HA in the absence of any
potential inhibitor, and were considered to constitute a
‘non-binding’ population. Preliminary studies showed that
increasing the ratio of PBS-HA to bacterial cells did not
eliminate this proportion of microorganisms (data not
shown). In all cases, inhibition of adhesion increased as
Colony Forming Units per millilitre X 107 (CFU 107 mL-1)
0.0 0.5 1.0 1.5 2.0
R
el
at
iv
e 
Fl
uo
re
sc
en
ce
 U
ni
ts
 (R
FU
)
0
200
400
600
800
1000
1200
1400
1600
1800
Fig. 1 Standard curve of relative fluorescent units (RFU) Vs colony
forming units per milliliter (CFU mL-1) for S. mutans
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concentration of dairy powder was increased (Fig. 2). Egg
albumin was included in this study as a negative control
protein, as it is not a component of milk or whey protein.
This protein exhibited no inhibition of adhesion across the
range of concentrations shown in Figs. 2 and 3.
WPI and DW were only found to exhibit inhibition of
adhesion at C125 lg mL-1, while WP showed no inhibi-
tion greater than its control adhesion value (0 lg mL-1)
across the range of concentrations examined (P B 0.05)
(Fig. 2a). CP and BMP were found to be very effective
inhibitors of S. mutans adhesion to PBS-HA (Fig. 2b), with
both dairy powders observed to be significantly more
effective than egg albumin at 17 and 33 lg mL-1,
respectively (P B 0.05). At 125 lg mL-1 both dairy
powders exhibited [80% inhibition of adhesion.
In the case of the WPCs (Fig. 2c), AWPC80, SWPC80
and SWPC35 were more effective than their control
adhesion values at 17, 33 and 66 lg mL-1, respectively
(P B 0.05). At 125 lg mL-1, no significant difference was
observed between SWPC80 and SWPC35, but both of
these dairy powders were less effective than AWPC80
(P B 0.05). It is interesting to note that both Sweet and
Acid WPC80 contain a high level of protein (*80%), and
approximately 8% fat (protein: fat = 10:1), yet exhibit
different levels of anti-adhesion activity. Glycomacropep-
tide (GMP), which is present in Sweet WPCs, is known to
inhibit adherence of cariogenic bacteria to S-HA in the oral
cavity [17–19], and can be incorporated into gum and
toothpastes as a preventative measure against plaque and
caries [20]. This constitutes an unusual finding in the
present study where PBS-HA was used, as AWPC80
exhibited higher levels of anti-adhesion activity when
compared to SWPC80 and SWPC35, yet does not contain
GMP, perhaps suggesting there is a more potent active
ingredient present in AWPC80 responsible for inhibiting
adhesion of S. mutans to PBS-HA.
It appears that of the commercial dairy powders exam-
ined, AWPC80, CP and BMP were the most effective
inhibitors of adhesion of S. mutans to PBS-HA. The exact
mechanism of how these dairy powders used in our study
can cause such inhibition is unclear and remains to be
elucidated. In order to speculate as to which component(s)
of dairy powders results in optimum anti-adhesion activity,
it is worthwhile to compare the compositional analyses of
each of these dairy products (Table 1). Cream powder
contains *16% protein and *50% fat (protein: fat = 1:3),
and buttermilk powder contains *30% protein and *10%
fat (protein: fat = 3:1), yet both of these dairy powders
were observed to be as effective as AWPC80 (protein:
fat = 10:1) at 125 lg mL-1. However, WPI contains an
even higher level of protein than the WPC80s, CP and
BMP (*87%) and negligible level of fat, yet resulted in
less anti-adhesive activity. These findings suggest that the
inhibitory effect of a dairy powder may be dependent on a
balance between protein and fat content of that particular
powder (Table 1). Also, the lactose content varies between
powders, but we have found that this carbohydrate has no
effect on the adhesion of S. mutans to PBS-HA, even at
1,000 lg mL-1 (data not shown), indicating that lactose is
not contributing to the inhibitory effect.
Assessment of anti-adhesive effect of milk components
In an attempt to identify the active component(s) of the dairy
powders examined, a selection of isolated milk components
were assessed for their inhibitory properties. Of the range of
purified milk proteins examined, neither a-lactalbumin, b-
lactoglobulin (A or B) nor BSA showed any inhibitory
activity higher than their control adhesion value across the
range of concentrations shown in Fig. 3a. However, the
caseins, lactoferrin and sodium caseinate were found to be
extremely potent inhibitors of S. mutans adhesion to PBS-
HA (Fig. 3b). At the lowest concentration examined
(17 lg mL-1), sodium caseinate was found to be signifi-
cantly more effective than all other components tested
(P B 0.05), but a-, b- and j- casein were observed to be
almost as effective at higher concentrations ([85% inhibi-
tion of adhesion). All milk proteins shown in Fig. 3b, with
the exception of lactoferrin, were observed to be significant
inhibitors of adhesion at the lowest concentration examined
Table 1 Compositional analysis of dairy powders used in this study (%)
SWPC80 AWPC80 SWPC35 WPI WP DW BMP CP
Protein 75.5 78.2 34.3 86.6 12.5 13 30.2 16.4
Fat 8 7.7 3.4 0.1 1 1.8 10.8 49.1
Moisture 7.5 6.3 5.4 5.8 3.1 3.5 3.9 2.1
Ash 3 5.9 6.2 2.6 9.5 0.8 6.9 4.5
Lactose 6 1.9 50.7 4.9 73.9 80.9 48.2 27.9
Total 100 100 100 100 100 100 100 100
SWPC80 sweet whey protein concentrate 80, AWPC80 acid WPC80, SWPC35 sweet whey protein concentrate 35, WPI whey protein isolate, WP
whey powder, DW demineralised whey, BMP buttermilk powder, CP cream powder
1502 Eur Food Res Technol (2008) 227:1499–1506
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(17 lg mL-1). Lactoferrin was not found to inhibit adhesion
at concentrations \66 lg mL-1, but exhibited potent inhi-
bition of S. mutans adhesion to PBS-HA at concentrations
above this.
A most interesting observation in the results presented
here is that sodium caseinate, a widely available and rel-
atively inexpensive industrial protein was the most
effective inhibitor of S. mutans adhesion to PBS-HA,
producing [80% inhibition of adhesion at the lowest
concentration examined (17 lg mL-1). This level of inhi-
bition was only observed for AWPC80 at a fourfold higher
concentration (66 lg mL-1). Previous research has shown
that sodium caseinate at 2% w/v in drinking water of rats
infected with S. mutans caused a reduction in caries [21]. It
was concluded that casein and sodium caseinate exhibited a
‘topical anticariogenic effect’, possibly due to incorpora-
tion of this protein into plaque, and subsequently
preventing demineralization of the enamel [22]. However,
the ability of sodium caseinate to inhibit the adherence of
S. mutans to HA may be more beneficial than preventing
demineralization of enamel.
In order to assess the relevance of these in vitro adher-
ence assays in relation to oral conditions in vivo, some
experiments were carried out using saliva-coated HA. S-
HA was prepared as described earlier (see ‘Preparation of
hydroxylapatite’) and an example of poor, medium and
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Fig. 2 Effects of dairy powders
on the adhesion of S. mutans to
PBS-HA: a whey protein isolate
(WPI, filled bar), whey powder
(WP, open bar) and
demineralised whey (DW, grey
bar), b buttermilk powder
(BMP, filled bar) and cream
powder (CP, open bar), and
c sweet whey protein
concentrate (WPC) 80
(SWPC80, filled bar), Acid
WPC80 (AWPC80, open bar)
and Sweet WPC35 (SWPC35,
grey bar). Egg albumin (dotted
bar) is included as a negative
control (Data = mean ±
standard deviation)
Eur Food Res Technol (2008) 227:1499–1506 1503
123
potent inhibitors of S. mutans adhesion to PBS-HA were
selected and their inhibitory properties assessed. These
were a-lactalbumin (poor), WPI (medium) and SWPC 80
and lactoferrin (potent). Similar trends were observed for
these dairy products/components regardless of whether
PBS-HA or S-HA was used, although it must be taken into
consideration that a higher proportion of S. mutans did not
bind to S-HA than for PBS-HA, thus the non-binding
population in the absence of inhibitor was much greater
(*30–40%) when S-HA was employed (Table 2). Saliva is
well known to reduce the adherence of S. mutans to HA,
and this observation has been reported previously by
researchers such as Liljemark et al. [23] and Clark et al.
[24]. Two hypotheses exist to explain this phenomenon: (a)
saliva alters the strength of the bond formed between S.
mutans and HA and (b) saliva changes the amount of
receptor or adsorption sites on HA beads, causing less
bacteria to bind [24]. a-lactalbumin did not exhibit any
significant level of inhibition greater than the control value
across the range of concentrations examined for both types
of coated HA, and was the least potent inhibitor of adhe-
sion (P = 0.05). Both WPI and SWPC80 showed similar
trends whether saliva was present or not, and lactoferrin
was observed to be effective at inhibiting adherence of S.
mutans to both PBS-HA and S-HA. This component of
milk has previously been shown to be a potent inhibitor of
adhesion of S. mutans (strain MT8148) to S-HA beads, and
the findings of the present study are consistent with the
work of Oho and co-workers [25].
It is well known that consumption of milk can be pro-
tective against occurrence of dental caries, and a study by
Vacca-Smith et al. [26] reported that treatment of S-HA
beads with milk caused a reduction in the adherence of S.
mutans GS-5. In the same study, lactose was shown to have
no function in the anti-adhesive properties of milk, which
has also been observed in our laboratory (data not shown).
Vacca-Smith and co-workers have demonstrated that
adhesion of S. mutans to S-HA was inhibited by a-, b- and
j-casein and suggested that the caseins were interacting
with both the S-HA beads and the bacterial cell surface,
producing a synergistic inhibition of adhesion effect. It is
possible that the same process is occurring in our adhesion
assays. Other foods and beverages which are capable of
inhibiting adhesion of cariogenic bacteria to S-HA include
herbal extracts, cranberry juice and water-soluble protein
fraction (WSPF) from hen-egg yolk, where 80, 90 and 61%
inhibition of S. mutans adhesion to HA has been reported
using 5, 250 g L-1 and 5 mg mL-1 of test substance,
respectively [7, 27, 28].
Ideally, to prevent initial colonisation, an inhibitory
substance against formation of dental caries should interact
specifically with both oral microorganisms and the tooth
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Fig. 3 Effects of milk and
whey components on the
adhesion of S. mutans to PBS-
HA: a a-lactalbumin ( ), b-
lactoglobulin A ( ), b-
lactoglobulinB ( ) and bovine
serum albumin ( ), and b a-
casein ( ), b-casein ( ), j-
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surface [21]. Preliminary experiments have indicated that
the HA beads used in our laboratory are being coated with
these dairy proteins, which is possibly contributing to a
reduction in adherence of S. mutans. Adsorption of proteins
to HA is quite complex since HA carries both positive and
negative charges due to the presence of Ca2+ and PO4
3-,
and the affinity of the former for negatively charged groups
is higher than the affinity for phosphate groups for posi-
tively charged residues [29]. However, we cannot report
that the inhibition of S. mutans to HA is solely due to this
process, as there are other possible mechanisms that could
be contributing to this inhibition, such as charge-charge-
repulsion/attraction, hydrophobic interactions, steric hin-
drance and possible interference to the surface binding
proteins associated with S. mutans.
Our adherence assays may be useful for the initial
screening of inhibitory substances capable of reducing/
preventing adherence of cariogenic bacteria to PBS-HA
prior to use in assays employing S-HA. Preliminary studies
using various test materials can be carried out in the
absence of saliva, and if favorable results are obtained, the
test material in question can subsequently be included in S-
HA adherence assays. Preparation of S-HA is a time-con-
suming process, and is susceptible to many natural
variations, for example diet, hormone fluctuations
(females), smoking and use of antibiotics or other drugs.
Also, logistical problems are often associated with saliva
collection as it is difficult if not impossible to collect all
samples and perform assays on the same day. Freezing can
have an undesirable influence on saliva, as adherence of S.
mutans can vary between different samples from an indi-
vidual after freezing [30]. In addition, precautions
associated with the handling of bodily fluids are not
required if PBS-HA is employed, and the adherence assay
is more sensitive as there is little variation associated with
using a buffer of which the exact composition is known.
Thus, our method using PBS-HA is a more convenient
model system for assessing the anti-adhesion properties of
various test materials of a cariogenic microorganism to a
tooth surface. In addition, the effect of an inhibitory sub-
stance on the adherence of S. mutans to uncoated HA can
provide useful information for the development of products
for individuals with xerostomia or ‘dry mouth syndrome’,
such as cancer patients receiving radiation treatment to the
head and neck, frequent users of narcotics and patients with
aplasia of the salivary glands [1]. Such conditions can
result in rampant caries, and a substitute for saliva may
have many beneficial effects. One such substitute is milk or
milk component based drinks, as these beverages possess
many of the biological and physical properties associated
with saliva [31], and would be easily consumed by patients
with these conditions.
The novel method described in this study enabled us to
carry out assays which were non-hazardous, rapid and easy
to perform, the results of which were highly reproducible,
with the coefficient of variation being typically \10%
between the RFU values recorded for replicates. This
adherence assay may also be useful in assessing the
inhibitory properties of other substances to HA (both PBS-
coated and saliva-coated). In conclusion, inhibition of S.
mutans adhesion to hydroxylapatite and therefore ability to
control dental caries is an application for dairy products.
The results presented here further substantiate the potential
of dairy based compounds to delay the progression of
dental caries by impairing adherence of the cariogenic
microorganism S. mutans to HA.
Table 2 Inhibition of adhesion values (%) of S. mutans to (i) Phosphate-buffered saline coated hydroxylapatite (PBS-HA) and Saliva-coated HA
(S-HA) observed for a-lactalbumin, whey protein isolate (WPI), sweet whey protein concentrate 80 (SWPC80) and Lactoferrin
Conc. (lg mL-1) a-lactalbumin WPI SWPC80 Lactoferrin
(i) PBS-HA
0 8.8a (x) ± 1.1 14.7a (x) ± 7.8 9.2a (w) ± 2.2 11.9a (x) ± 4.9
17 8.2a (x) ± 1.5 25.6b (x,y) ± 12.7 14.3a (w,x) ± 1.9 16.1a (x) ± 3.3
33 9.6a (x) ± 2.2 25.2b (x,y) ± 11.4 21.6b (x) ± 5.8 18.5a,b (x) ± 6.2
66 9.6a (x) ± 2.5 32.2b (x,y) ± 12.4 39.2b (y) ± 6 33.3b (y) ± 7.1
125 12a (x) ± 7.8 42.9b (y) ± 20.1 66.5c (z) ± 5.9 82.7c (z) ± 13.8
(ii) S-HA
0 34.9a (x) ± 4.3 31.1a (x) ± 2.8 35.1a (w) ± 6.3 33.8a (x) ± 9.1
17 33a (x) ± 4.5 43b (x,y) ± 4.5 65.3b (x) ± 4.4 58.7b (y) ± 11.5
33 33.7a (x) ± 2.8 50.9b (y) ± 7.5 72.7b (x,y) ± 6.2 66.4b (y) ± 7.7
66 35.9a (x) ± 1.9 54.6b (y) ± 1.5 82.8b (z) ± 7.3 85.8b (z) ± 9.6
125 37.2a (x) ± 1.8 55.2b (y) ± 7.9 85.8b,c (z) ± 9.6 87.1c (z) ± 10.6
Values are ± standard deviation. Means with the same letters are not significantly different (at the 5% significance level). Letters within the same
rows indicate significant differences between test materials for (i) PBS-HA and (ii) S-HA, while letters within the same column (in parentheses)
indicate significant differences between concentrations within the individual test material
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